The challenge of discovering patient-level cardiovascular risk factors in chronic kidney disease

Kidney International

Volumn 73, Issue 12, 2008, Pages 1340-1342

  Agarwal, R ^a,b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; FIBRINOGEN; HOMOCYSTEINE; INTERLEUKIN 6; PLASMINOGEN ACTIVATOR INHIBITOR 1; RENIN;

ALBUMINURIA; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CAUSAL ATTRIBUTION; CHRONIC KIDNEY DISEASE; DECISION MAKING; HUMAN; LEUKOCYTE COUNT; NOTE; PRIORITY JOURNAL; RISK FACTOR; SCORING SYSTEM;

EID: 44449110677     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2008.124     Document Type: Note

References (11)

1. Dawber TR, Meadors GF, Moore FE Jr. Epidemiological approaches to heart disease: the Framingham Study. Am J Public Health Nations Health 1951; 41: 279-281.
2. Dawber TR, Moore FE, Mann GV. Coronary heart disease in the Framingham study. Am J Public Health Nations Health 1957; 47: 4-24.
3. Pepe MS. The Statistical Evaluation of Medical Tests for Classification and Prediction. Oxford University Press: Oxford, 2004, pp 1-302.
4. Wang TJ, Gona P, Larson MG et al. Multiple biomarkers for the prediction of first major cardiovascular events and death. N Engl J Med 2006; 355: 2631-2639.
5. Go AS, Chertow GM, Fan D et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296-1305.
6. Muntner P, Hamm LL, Kusek JW et al. The prevalence of nontraditional risk factors for coronary heart disease in patients with chronic kidney disease. Ann Intern Med 2004; 140: 9-17.
7. Jamison RL, Hartigan P, Kaufman JS et al. Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial. JAMA 2007; 298: 1163-1170.
8. Schiffrin EL, Lipman ML, Mann JF. Chronic kidney disease: effects on the cardiovascular system. Circulation 2007; 116: 85-97.
9. Weiner DE, Tighiouart H, Elsayed EF et al. Inflammation and cardiovascular events in individuals with and without chronic kidney disease. Kidney Int 2008; 73: 1406-1412.
10. Shlipak MG, Fried LF, Cushman M et al. Cardiovascular mortality risk in chronic kidney disease: comparison of traditional and novel risk factors. JAMA 2005; 293: 1737-1745.
11. Khera A, de Lemos JA, Peshock RM et al. Relationship between C-reactive protein and subclinical atherosclerosis: the Dallas Heart Study. Circulation 2006; 113: 38-43.